← Browse by Condition
Medical Condition
metastatic gastric cancer
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT07315854 Phase 2
Recruiting
Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
Enrollment
32 pts
Location
China
Sponsor
Beijing Friendship Hospital
NCT06121700 Phase 2
Recruiting
Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer
Enrollment
55 pts
Location
China
Sponsor
Fudan University